Genetically edited CD34(+) cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells

Genetic editing of induced pluripotent stem (iPS) cells represents a promising avenue for an HIV cure. However, certain challenges remain before bringing this approach to the clinic. Among them, in vivo engraftment of cells genetically edited in vitro needs to be achieved. In this study, CD34(+) cel...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Proc Natl Acad Sci U S A
Main Authors: Morvan, Maelig G., Teque, Fernando, Ye, Lin, Moreno, Mary E., Wang, Jiaming, VandenBerg, Scott, Stoddart, Cheryl A., Kan, Yuet Wai, Levy, Jay A.
Formato: Artigo
Idioma:Inglês
Publicado: National Academy of Sciences 2021
Assuntos:
Biological Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158014/
https://ncbi.nlm.nih.gov/pubmed/33975958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2102404118
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares